Stem cell therapy slows relapsing-remitting MS - study

iStock/PeopleImages

Stem cells harvested from an individual’s own bone marrow or blood can slow progression of multiple sclerosis, according to Swedish research.

Autologous haematopoietic stem cell transplantation (aHSCT), used to treat blood cancers, involves harvesting stem cells followed by chemotherapy and antibody treatment.